This activity is jointly provided by Global Education Group and Physicians’ Education Resource®, LLC.

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioner Continuing Education

This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through joint providership of Global Education Group and PER. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 1561024. This activity is approved for 1.0 contact hour(s) which includes 0.00 hour(s) of pharmacology.

Activity ID #2821E.

This activity was planned in accordance with AANP CE Standards and Policies.

Acknowledgement of Commercial Support

This activity is supported by educational funding provided by GlaxoSmithKline LLC.


Release Date: January 31, 2019
Expiration Date: January 31, 2020
Media: Internet - based

Activity Overview

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, yet it is both preventable and treatable. Characterized by airflow limitation and persistent respiratory symptoms, COPD is more prevalent among smokers and individuals older than 40 years. Comorbidities are frequent in COPD and are associated with further impact on patients’ quality of life, frequency of exacerbations, and morbidity. The clinical management of COPD is further challenged by recognition of comorbidities, effect on patients’ symptoms, and the concurrent treatment with COPD. During this on-demand webinar, faculty will provide a comprehensive approach to guideline-based diagnosis and treatment and then share insights on enhancing patient satisfaction and improving outcomes. Management of 2 major comorbidities, cardiovascular disease and sleep disturbances, will be highlighted.

Acknowledgement of Commercial Support

This activity is supported by educational funding provided by GlaxoSmithKline LLC.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review audio files/content until you finish the presentation.
  • At the end of the activity, educational content/audio files will be available for your reference.
  • In order to receive a CME certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME certificate upon completion of these steps.

Target Audience

This continuing medical education (CME) activity is intended primarily for primary care and specialty nurse practitioners involved in the treatment and management of patients with COPD.

Educational Objectives

Upon successful completion of this activity, you should be better prepared to:

  • EXPLAIN guideline-based procedures for diagnosing COPD
  • SELECT treatment options for COPD based on individual patient needs
  • DISCUSS the effects of comorbidities on worsening of symptoms and outcomes of COPD
  • DESCRIBE key roles of interprofessional team members in carrying out effective transitions of care for patients with COPD

Faculty, Staff, and Planners' Disclosures


Barbara P. Yawn, MD, MSc, FAAFP
Adjunct Professor, Department of Family and Community Health
University of Minnesota
Minneapolis, Minnesota
Chief Science Officer, COPD Foundation
Washington, DC

Disclosures: Consultant: Boehringer Ingelheim, GlaxoSmithKline, Novartis

The staff of PER® have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By